The Henry Ford Cancer Institute has installed Michigan's first clinical LumaGem molecular breast imaging system by molecular imaging developer Gamma Medica.
The new system can be found at Henry Ford West Bloomfield Hospital, one of the institute's locations, where it will be used to provide diagnostic and secondary screenings to women who have a higher risk of breast cancer and those with dense breast tissue.
The new technology was made possible by philanthropic support and donations, according to Gamma Medica.
